✦ LIBER ✦

Portal hypertension associated with idiopathic retroperitoneal fibrosis

✍ Scribed by B. Eiseman; K. S. Yeoh

Publisher: John Wiley and Sons
Year: 1962
Tongue: English
Weight: 313 KB
Volume: 50
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.18005022021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Portal hypertension as a complication of

Portal hypertension as a complication of idiopathic retroperitoneal fibrosis

✍ F. Mosimann; B. Mange 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

Retroperitoneal fibrosis associated with

Retroperitoneal fibrosis associated with aortitis

✍ Masataka Kuwana; Shu Wakino; Tadashi Yoshida; Mitsuo Homma 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 1 views

Retroperitoneal fibrosis—an association

Retroperitoneal fibrosis—an association with hyperuricaemia

✍ T. H. Cullen 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

Idiopathic portal hypertension (noncirrh

Idiopathic portal hypertension (noncirrhotic portal fibrosis), thrombosis in portal venous system and protein C deficiency to the editor

✍ N. C. Nayak 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Evaluation of patients with portal hyper

Evaluation of patients with portal hypertension-associated pulmonary artery hypertension

✍ Mandell, M S 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 63 KB

Noncirrhotic presinusoidal portal hypert

Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis–associated liver disease

✍ Peter Witters; Louis Libbrecht; Tania Roskams; Kris De Boeck; Lieven Dupont; Mar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.